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WC studied the expression of the human cellular glutathionc peroxidase (GPx) gene, from which a key enzyme containing sclenocysteine (Sty) at 
the active site is produced. Expression of some human GPx gene mutants in COS-7 cells revealed that the 5’ untranslated region (utr) was necessary 
for expression of the GPx gene, since mutant genes having 10 base pairs (bps) at the S’utr (the complete had 311 bps) expressed GPx at very low 
levels. The genes with 31 I or 405 bps at the S’utr wcrc better expressed than those having 257 bps. The GPx gene having 133 bps at the 3’utr (80 
bps shorter than the entire length) was highly expressed. This deletion did not influence xpression. We constructed some mutants in which 3 bases 
were altered at the upstream region of the Sty UGA codon i. *. the frame ,of the GPx Ben.+ by site-directed mutagenesis. GPx expression decreased 
but the expression was restored. Therefore, the upstream region of the in-frame Sty codon was nL?t essential in the Sty decoding mechanisms. Finally, 
the S’utr was essential for the expression of GPx gene. However, the deletion of a part of the 3’utr and the siw-directed mutation upstream of the 
Sty codon did not show drastic effects on the expression. 
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1, INTRODUCTION 
Selenium is an essential trace element in humans; a 
Se deficiency causes Keshan disease which is endemic 
in China [ 11. The syndrome is relieved by administration 
of selenious acid. Selenium presents as selenocysteine 
(Sty) in some seleno-proteins, such as cellular glutathi- 
one peroxidase (GPx) [2], plasma glutathione perox- 
idase 133, S’-iodothyronine monodeiodinase (S’DI) [4], 
plasma seleno-protein (SeP) [S], and phospholipid hy- 
droperoxide glutathione peroxidase (PHGPx) [6]. We 
previously reported the sequences of human cellular 
GPx cDNA and genomic DNA [7,8]. The Sty codon on 
mRNAs of these proteins is UGA which also functions 
as a stop codon. Half of all stop codons in mammals is 
UGA [9]. Thus, UGA has two roles, namely termina- 
tion and Sty. Several years previously, a serine tRNA 
corresponding to UGA codon was discovered and re- 
ferred to as natural opal suppressor tRNA [lo]. A minor 
serine tRNA having NCA of anticodon has been se- 
quenced [ll]. Recently, it has been reported that this 
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natural suppressor tRNA binds Sty [12] and that the 
carbon skeleton colnes from serinc [13]. We have re- 
ported the mechanisms of in vitro enzymatic synthesis 
of Sty-tRNA from Ser-tRNA in mammals [14,15]. This 
mechanism is similar to that in Esckrichia CC&, in which 
the biosynthetic mechanism of formate dehydroyenase 
(FDH) has been clarified [16]. 
The discrimination mechanisms of the Sty UGA 
codon from the many UGA codons on mRNAs are of 
interest. It is possible that a particular sequence in 
mRNA of seleno-proteins can decode Sty on ribo- 
somes. Some models of the secondary structure of 
mRNAs have been reported [17-193. The model of 
human GPx mRNA postulated by Zinoni et al. [ 181 did 
not fit with the mRNAs of mammalian other seleno- 
proteins. This model was derived from the stem-loop 
model of the FDH in E. co/i. This discrepancy suggests 
that there is no common secondary structure between 
mRNAs of seleno-proteins from eukaryotes and 
prokaryotes for the Sty decoding system. The stem-loop 
model at the 3’ untranslated region (utr) in SD1 mRNA 
postulated by Berry [i9] is currently the most appropri- 
ate, but it does not completely fit all mRNAs of seleno- 
proteins, such as that of PHGPx. Our model for GPx, 
which contained a stem-loop structure surrounding the 
Sty UGA codon [17], also did not fit with all mRNAs 
of seleno-proteins. However, it is possible that a key 
structure for recognition of the Sty UGA codon pres- 
ents in the frame of mRNAs of mammalian seleno- 
proteins and is located near the Sty UGA codon. In 
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order to understand these mechanisms, we constructed 
some deletion and site-specific mutants of the GPx gene, 
and investigated the influence of those mutations on the 
expr&ott of GPx in COS-7. 
2. EXPERIMENTAL 
2.1, Consrrrrcrior~ o/expression vcxcor 
Genetic procedures and recombinant techniques were carried out 
according to the literature [20], Human GPx genes used were the 
cDNA and gcnomic DNA previously reported [7,8]. Genomic DNA 
and cDNA of GPx were subcloned in pcD [21] or pSV [22] which 
contain the SV40 ori and early promoter. Plaamid pSVM has the dilJr 
gene deleted and contains the mouse mammary tumor virus (MMTV) 
promoter which was induced with denamethasone (dxm). 
2.2. Sire-directed n~u~agenesls 
New constructs containing mutations were prepared using the ol- 
igonuclcotide-directed in vitro mutagenesis syslcm Ver. 2 (Amers- 
ham). A restriction fragment from pcDcGPxdA with HindIll and 
BoRl was subcloned into M 13mp 19 and sin&-stranded DNA was 
prepared as a tcmplatc for mutagenesis. Oligonucleotides synthesized 
using the AU1 model 382A were as follows (the positions of mutations 
arc underlined). 
5'-GCCTCAGAGAGACGCCAC-3' (for cGPxbpS) 
5'-GTGCCTCACAAAGACGCC-3' (forcGPxbp3) I_ 
Mutation was confirmed by sequencing with Sequenase Ver. 2.0 
(USB). The mutated restriction frngmcnls from replicative form 
DNAs of recombinant M I3 were fused into the fragment made from 
pcDcGRdA. 
2.3. Expression of vectors br COS-7 
COS-7 cells were cultured in Dulbecco’s modified Eagle’s Medium 
(Flow Lab.) containing 10% fetal calf serum (Irvine Sci.). Expression 
vectors were introduced into COS-7 by the DEAE-dcxtran method. 
After transfection, the medium w;\s rcplaocd with that containing 7.5 
PM sodium sclenite, and the trnnsfected cells were cultured for 48 h. 
Mutants 
The expression level in COS-7 was checked with pSV-p-galactosidase 
(Promcga). 
2.4. Western-blor UnOiJbS 
Expression of GDx was analyzed by Western blotting. Cells col- 
lcrtcd were disrupted ty sonication nnd cellular extracts were sepa- 
rated by SDS-PAGE (12% ncrylamideh Proteins in gels were electro- 
blotted onto Immobilon mcmbrancs (Milliporc). GPx was detected by 
immune-s!aining with rabbit serum immunized with bovine GPx 
(Sigma), which clearly reacted with human GPx, and subsequently 
with anti-rabbit IgG goat serum conjt@ed horseradish peroxidase 
(MBL). Bnnds were visualized using an immune-staining kit (Konika). 
3. RESULTS 
We investigated the role of the S’utr and 3’utr of the 
human GPx gene on GPx expression. Fig. 1 shows a 
map of GPx gene in some expression vectors used in this 
study. These vectors were composed of genomic GPx 
and cDNA in pcD, pSV and pSVM based upon the 
SV40 promoter. In pcDcGPxdA, the S’utr of GPx gene 
has all 311 base pairs (bps) but the 3’utr is 133 bps, 
deleted by 80 bps. Plasmid pcDcGPxl0 has a complete 
3’utr (213 bps) but the S’utr is only 10 bps. The vector 
containing a genomic DNA with a 278 bps intron has 
a different sized S’utr. In comparison with the 3 11 bps 
at the S’utr of cDNA, pSVgGPx and pcDgGPx have 
408 and 257 bps at the S’utr, respectively. These vectors 
were transfected into COS-7 by the DEAEdextran 
method. 
The results of the transient expression of those plas- 
mids containing cDNA and genomic DNA are shown 
in Fig. 2A and B, respectively. Lane 1 in Fig. 2A shows 
the profile of the authentic human GPx enzyme. GPx 
in pcDcGPxdA was not expressed in the absence of Se 
pSVg3Px 5’utr Exon 
AK * 
lntron Exon 3’40 
TAO 
AT0 * TAQ 
pcDcGPxdA 
pSVMcGPxdA 
GPX 
expression 
=u 
Fig. 1. Some deletion mutants of GPx gene exprcssexl in COS-7. The expression levels of GPx are indicated on the right side. Asterisks indicate 
the positions of the Sty UGA codon. 
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Fig. 2. Profiles of GPx exprcsscd in COS-7 visualized by Western- 
blatting. Panels A and I3 contain cDNA and genomic DNA. rcspec- 
tivcly. Panel A: (I) human GPx protein 0. I yg; (2) pSG5 control 
plasmid containing b-globin gene; (3 and 4) pcDcGPxdA; (5) 
pcDcGPxl0; (6 and 7) pSVMcGPxdA. Lane 3 is in the absence of SC 
in medium. Lane 6 is induced with dxm but 7 is not. Panel B: (1) 
positive control pcDcGPxdA; (2) pSVgGPx; (3) pcDgGPx. Arrows 
indicate the position of the GPx cnzymc. The levels of the expression 
of each plasmid arc shown in Fig. 2 by f++, -t+-, or 2. 
in the medium (lane 3). However, GPx was expressed 
in the presence of Se (lane 4) at the position shown by 
the arrow on the right side. Selenium is necessary for the 
expression of GPx gene in 0X-7. Lane 2 is the control 
plasmid containing/&globin gene and GPx was not ex- 
pressed. Vector pcDcGPxl0, which contained only 10 
bps at the S’utr, was hardly expressed GPx in CGS-7 as 
shown in lane 5. Vector pSVMcGPxdA, which con- 
tained a promoter induced by dxm, was expressed GPx 
at the same level as that of pcDcGPxdA in the presence 
of an inducer (lane 6) but at low levels in the absence 
of dxm (lane 7). Plasmid pSVMcGPxl0, which con- 
tained the dxm promoter and IO bps at the Sutr, ex- 
pressed little GPx in the presence of inducer (data not 
shown). Thus, both pcDcGPxl0 and pSVMcGPxl0 
were expressed GPx at very low levels in COS-7. These 
results showed that the Sutr was necessary for the ex- 
pression of human GPx. Plasmids pcDcGPxdA and 
pSVMcGPxdA, which harbour an 80 bps deletion at the 
3’utr, were highly expressed GPx. This suggests that 
part (80 bps) of the 3’utr is not necessary for the GPx 
expression. 
Fig. 2B shows the expression of genomic DNA in the 
presence of Se. The expression of pSVgGPx (lane 2)9 
which contained 408 bps at the T’utr, was the same level 
as that of pcDcGPxdA (lane l), which contained 311 
bps at the S’utr. The expression of pcDgGPx, which 
contained 257 bps at the S’utr, was at a low level (lane 
3). The possibility cannot be excluded that the muta- 
tional alteration affected transcription of mRNA stabil- 
ity. Overall, however, we found that the S’utr was im- 
portant for the expression of GPx. Fig. 213 also showed 
that an intron in gcnomic GPx genes did not influence 
expression. These results are summarized in Fig. 1. We 
confirmed the expression of GPx not only by Western 
blotting but also by the direct measurement of GPx 
activity in cell extracts. From this, we estimated the 
amount of GPx enzyme xpressed with pcDcGPxdA to 
be about 1 ,ug/ml medium and 3.1 pg/106 cells. This is 
the same level as that of other proteins expressed in 
cultured cells. This showed that the translation level of 
GPx as a seleno-protein was reserved by the turnover 
of Sty-tRNA, which was synthesized by a system con- 
taining several enzymes [ 14,151, although tRNAScy was 
at low levels in the cytosol. 
Next, we investigated the influences of some base 
changes in the GPx frame, especially the region up- 
stream of the Sty UGA codon. We constructed two 
GPx genes by site-directed mutagenesis. The mutated 
positions are shown in Fig. 3. The strategy of the mu- 
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Fig. 3. Design for sitc.dircctcd mutagenesis. The upper area shows the 
positions of mutation indicated by underlines. The lower area shows 
the stem-loop model of’ mutants (cGPxbp5 and cGPxbp3) and the 
original GPx gcnc (pcDcGPxdA indicated by WTbp6). The numbers 
under codons show codon usage. 
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&I’>; bp5 cGPx bp.3 
Fig. 4. Sequence for confirmation of base changes in mutants by 
site-directed mutagenesis. (Left) WTbpG (pcDcCiPxdA); (center) 
cGPxbp5; (right) cGPxbp3. On the right side, the position of Sty TGA 
is indicated and the mutated bases are also indicated between the 
photos. 
tagenesis was silent mutation (changes of bases and no 
change of amino acids), and similar codon usage. In the 
original cGPx gene (pcDcGPxdA) which highly ex- 
pressed GPx, a stem between bases after and before the 
Sty UGA codon can be formed as shown in Fig. 3A. 
The mutant cGPxbp5 has a base change from C to T 
at the 4th base upstream of the Sty UGA codon and the 
number of bps is reduced from 6 to 5. The mutant 
cGPxbp3, made from cGPxbp5, has base changes from 
C to C and from C to T at the 1st and 3rd positions 
upstream of the Sty UGA codon, respectively. The mu- 
tation was confirmed by standard dideoxy sequencing 
as shown in Fig. 4. 
The results of expression of these mutants in COS-7 
are shown in Fig. 5. The expression of cGPxbp5 (lane 
4) was half that of the original pcDcGPxdA (lane 3). 
The expression level of cGPxbp3 (lane 5) was the same 
level as that of cGPxbp5. These base changes did not 
cause drastic effects in the expression of the GPx gene 
because clear expression was found in both mutants. 
Thus, we considered that the upstream region of the Sty 
codon did not have an essential role in effective GPx 
expression. Codon usage of UCU at the mutated posi- 
tion in cGPxbp5 and cGPxbp3 was 13.2, which was less 
than the 17.7 of UCC in the original pcDcGPxdA [9]. 
Codon usage of UUG in cGPxbp3 was 1 I .O, which was 
less than the 19.9 of CUC in pcDcGPxdA and 
cGPxbp5. Thus, these values represent low codon usage 
[9]. Therefore, the low expression of GPx by cGPxbp5 
and cGPxbp3 might be dependent upon low codon 
usage at the upstream region of the Sty UGA codon. 
4. DISCUSSION 
In mammalian S’DI, it has been reported that a large 
stem-loop structure, located near 1000 nucleotides 
downstream from the peptide termination codon, is es- 
sential for expression of 5’DI [19]. This model is the best 
to date. The similar secondary structure model is also 
found at the GPx S’utr which is essential for the expres- 
sion of GPx, as shown in Fig. 6. This model at the 3’ut.r 
of 5’DI mRNA may fit some mammalian seleno-pro- 
teins. However, the 3’utr in many mRNAs contains 
more A and U, and the base pairing is generally related 
to the stability of the mRNAs [23]. Therefore, the base 
pairing at the 3’utr in the model by Berry may not be 
related to discrimination of the Sty UGA codon but 
with the stability of 5’DI mRNA. It is oossible that the 
mutant mRNA_with a deletion at the 3’utr is labile and 
cannot produce 5’Dl activity. 
In this study, we showed that the Sutr of the GPx 
A 
A C 
A 
A GU 
G-C 
a-c 
c u 
C-ciu 
C-G 
Fig. 5. Profiles of GPx expressed in COS-7 with mutants cGPxbp5 and 
cGPxbp3 by Western blotting. (Lane :) Human CR cnQ-tnc 0. I fig: 
(2) blank; (3) WTbp6 (pcDcGPxdA); (4) cGPxbp5; (5) cGPxbp3. 
Arrow indicates the position of GPx enzyme. The levels of GPx cx- 
pression arc indicated below the blot. 
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Fig. 6. A secondary structure model at the 5’utr and 3’utr on the 
mRNA of pcDcGPxdA, according to the literature [ 191. 
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Table 1 
Chain lenghts of the 5’ and 3’ untranslated rtigions in mRNAs of some 
mammalian seleno-proteins 
Seleno-proteins S’utr f’utr Refs. 
Human GPx 319 213 
Murine GPx 37 214 ;I; 
5’DI 6” 1,313 
SeP 34” 1,598 i 
Plasma GPx 53” 871” [31 
PHGPx 206 [61 
“These are from cDNA published in the papers and may be shorter 
than that from those mature mRNAs. 
gene was necessary for expression of the GPx gene. We 
summarized the sizes of the S’- and 3’utr of cDNA of 
seleno-proteins in Table I. Those are estimated from 
cDNA and may not be complete mature mRNAs. The 
size of the S’utr of human cGPx is longer than other 
seleno-protein mRNAs as shown in Table 1. As shown 
in Table I, the sizes of mammalian seleno-protein 
mRNAs are random and it is difficult to obtain a gen- 
eral profile for decoding the Sty UGA codon from the 
lengths of the S’- and 3’utrs. 
A stem-loop structure downstream of the Sty UGA 
codon on FDH mRNA in IZ. coil can decode Sty [ 181. 
Recently, a new mechanism for UGA termination 
events in E. coli has been proposed as follows. The 
5’-UCAUCA-3’ motif in 16 S rRNA initially interacts 
with the stop UGA codon, then RF-2 recognizes this 
complex [24]. However, this sequence was not found at 
a similar region in mammalian 18 S rRNA. The primary 
structure of RF-2 of E. coli differs from ma;xnalian 
eRF. We made an expression vector in E. co/i, which 
contained the runaway ori and Tat promoter, and an 
expression vector in Saccharonzyces cerevisiae, which 
contained the glyceraldehyde-3-phosphate dehydroge- 
nase promoter. However, these two vectors did not ex- 
press GPx in E. cob and S. cerevisiae, respectively. This 
suggests that the UGA decoding systems of both stop 
and Sty differ between mammals and bacteria. 
Figs. 2 and 5 do not show any small peptides termi- 
nated at the Sty UGA codon and stained with the pol- 
yclonal antiserum for GPx at the electrophoretic front. 
Meanwhile, the polyclonal antibody for 5’DI reacted 
well with the small peptide terminated at the Sty UGA 
codon [19]. In the case of expression of SDI, the main 
product was this small peptide terminated at the Sty 
UGA codon. Meanwhile, this study with mutants of 
GPx gene suggests that the decoding information of the 
Sty codon is stored after mutagenesis. 
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